SURAKSHA

Suraksha Diagnostic, a small-cap player in the healthcare services sector, has recently faced a downgrade in its stock rating. The company's current stock price stands at Rs 318.00, down from a previous close of Rs 323.50. Over the past year, Suraksha Diagnostic has experienced a flat financial performance, with a reported profit after tax (PAT) of Rs 7.39 crore for Q4 FY24-25, reflecting a decline of 6.1% compared to the previous four-quarter average. The stock has generated no returns over the past year, despite a 34% increase in profits. Suraksha Diagnostic maintains a low debt-to-equity ratio of 0, indicating a stable financial position. However, with a price-to-book value of 9.2 and a return on equity (ROE) of 18.5, the valuation appears expensive. The company has also shown healthy long-term growth, with operating profit increasing at an annual rate of 89.29%.